Search research articles
Contact Us
Filters
Showing results (71-80 of 76) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 76 results.
Blood
|
March 4, 2024
CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy
Johannes Sam, Thomas Hofer, Christine Kuettel, et al.
Nature Communications
|
October 31, 2024
Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemia
Rebekka Wegmann, Ximena Bonilla, Ruben Casanova, et al.
Cancer Cell
|
January 22, 2021
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support
Anja Irmisch, Ximena Bonilla, Stéphane Chevrier, et al.
Nature Medicine
|
May 27, 2025
Feasibility of multiomics tumor profiling for guiding treatment of melanoma
Nicola Miglino, Nora C Toussaint, Alexander Ring, et al.
Nature Communications
|
July 13, 2026
A tumor profiling resource for ovarian cancer: insights into chemotherapy-driven heterogeneity and personalized treatment strategy
Francis Jacob, Rebekka Wegmann, Joanna Ficek-Pascual, et al.
Science Translational Medicine
|
June 14, 2019
Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy
Christina Claus, Claudia Ferrara, Wei Xu, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 76) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 76 results.
Blood
|
March 4, 2024
CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy
Johannes Sam, Thomas Hofer, Christine Kuettel, et al.
Nature Communications
|
October 31, 2024
Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemia
Rebekka Wegmann, Ximena Bonilla, Ruben Casanova, et al.
Cancer Cell
|
January 22, 2021
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support
Anja Irmisch, Ximena Bonilla, Stéphane Chevrier, et al.
Nature Medicine
|
May 27, 2025
Feasibility of multiomics tumor profiling for guiding treatment of melanoma
Nicola Miglino, Nora C Toussaint, Alexander Ring, et al.
Nature Communications
|
July 13, 2026
A tumor profiling resource for ovarian cancer: insights into chemotherapy-driven heterogeneity and personalized treatment strategy
Francis Jacob, Rebekka Wegmann, Joanna Ficek-Pascual, et al.
Science Translational Medicine
|
June 14, 2019
Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy
Christina Claus, Claudia Ferrara, Wei Xu, et al.
Page
of 8